Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by quicksilver545on Oct 26, 2016 4:43pm
183 Views
Post# 25389694

RE:RE:RE:Buying

RE:RE:RE:BuyingI'll admit I have been buying at these levels as well. With recent insider purchases, positive cashflow, NAV at 76 cents, and a high margin business, this looks pretty good to me.

If Hilary wins, I see this as a plus for the stock. Clinton has a $2.5 billion plan to fund more treatment centres for addictions, and it certainly seems like addiction health is gaining more exposure. As the number of people able to access treatment grows, I would expect the loans side of this business to expand as well.

Also like the choice to enter into high-margin software business. I work in the healthcare industry here in Canada, and pretty much all practitioners are going digital, from billing to health records. Great space to be in. 

Would like to know more about this management team, though. Surprising that they cannot find a CFO yet. Perhaps we will know more in the next release.

In any case, I think this stock has two great things going for it: Being extremely undervalued with little debt, and having great growth potential in a high margin space.




Bullboard Posts